Select your country
Select a country to go to the website of the respective STADA sales company.
United Kingdom (4)
STADA records satisfactory development in the first nine months of 2013 – sales growth of 8 percent – adjusted EBITDA margin at 19.8 percent…
STADA expands biosimilar range and in-licenses filgrastim product from Apotex Inc.
STADA strengthens business activities in Russia with the signing of a contract for the purchase of the branded product portfolio Aqualor® fo…
Foregoing the use of external consultants brings millions in savings:
STADA establishes IT shared service center for the Group
STADA expands diagnostics portfolio:
New user-friendly self-tests for five areas of indication
STADA purchases British OTC manufacturer Thornton & Ross
STADA with dynamic sales growth in the first half of 2013
STADA: Dr. Axel Müller resigns his Executive Board mandate
STADA in exclusive negotiations on the purchase of the British OTC manufacturer Thornton & Ross